- Home
- PRTS vs CNTB Comparison
PRTS vs CNTB Comparison
Compare PRTS & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- CNTB
- Stock Information
- Founded
- PRTS 1995
- CNTB 2012
- Country
- PRTS United States
- CNTB United States
- Employees
- PRTS N/A
- CNTB N/A
- Industry
- PRTS Auto & Home Supply Stores
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- CNTB Health Care
- Exchange
- PRTS Nasdaq
- CNTB Nasdaq
- Market Cap
- PRTS 50.4M
- CNTB 55.2M
- IPO Year
- PRTS 2007
- CNTB 2021
- Fundamental
- Price
- PRTS $0.91
- CNTB $0.68
- Analyst Decision
- PRTS Buy
- CNTB Strong Buy
- Analyst Count
- PRTS 3
- CNTB 1
- Target Price
- PRTS $1.60
- CNTB $8.00
- AVG Volume (30 Days)
- PRTS 1.0M
- CNTB 18.2K
- Earning Date
- PRTS 03-25-2025
- CNTB 04-15-2025
- Dividend Yield
- PRTS N/A
- CNTB N/A
- EPS Growth
- PRTS N/A
- CNTB N/A
- EPS
- PRTS N/A
- CNTB N/A
- Revenue
- PRTS $588,846,000.00
- CNTB $24,116,000.00
- Revenue This Year
- PRTS $5.00
- CNTB $382.35
- Revenue Next Year
- PRTS $5.53
- CNTB N/A
- P/E Ratio
- PRTS N/A
- CNTB N/A
- Revenue Growth
- PRTS N/A
- CNTB N/A
- 52 Week Low
- PRTS $0.68
- CNTB $0.68
- 52 Week High
- PRTS $1.66
- CNTB $2.66
- Technical
- Relative Strength Index (RSI)
- PRTS 41.74
- CNTB 30.43
- Support Level
- PRTS $0.85
- CNTB $0.80
- Resistance Level
- PRTS $1.08
- CNTB $0.84
- Average True Range (ATR)
- PRTS 0.11
- CNTB 0.06
- MACD
- PRTS -0.00
- CNTB -0.01
- Stochastic Oscillator
- PRTS 18.78
- CNTB 0.00
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.